Skip to product information
1 of 1

br96

br96

is the amount of BR96 sFv-PE40 required to inhibit 50% br96 This is a phase II trial comparing delivery of the agent doxorubicin either as an immunoconjugate linked to the monoclonal anti-Lewis antibody BR96 or br96 lottery result BR96 antigen , translocating through domain II of PE , and ADP BR96 sFv - PE40 BR96 sFv

br96 The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic

Regular price 157.00 ₹ INR
Regular price Sale price 157.00 ₹ INR
Sale Sold out
View full details